Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]

Stephan Seitz, Stefan Buchholz, Andrew V. Schally*, Arumugam R. Jayakumar, Florian Weber, Andrea Papadia, Ferenc G. Rick, Luca Szalontay, Andrea Treszl, Frank Köster, Olaf Ortmann, Florian Hohla

*Corresponding author for this work
14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]'. Together they form a unique fingerprint.

Medicine & Life Sciences